Ketamine clinical trials at UC Davis
2 in progress, 1 open to eligible people
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
open to eligible people ages 1 year and up
The goal of this clinical trial is to determine if treatment of patients with two doses of ketamine plus levetiracetam versus levetiracetam alone leads to more effective control of status epilepticus.
Sacramento, California and other locations
Morphine or Ketamine for Analgesia
Sorry, not yet accepting patients
Pain is common in children presenting to the emergency department but is frequently undertreated, leading to both short- and long-term consequences. Morphine is the standard treatment for children with moderate to severe acute pain, but its use is associated with serious side effects and caregiver and clinician concerns related to opioid administration. The investigators aim to determine if sub-dissociative ketamine is non-inferior to morphine for treating acute pain and a preferable alternative for treating acute pain in children because of its more favorable side effect profile and potential long-term benefits related to pain-related function, analgesic use/misuse, and mental and behavioral health outcomes.
Sacramento, California and other locations
Our lead scientists for Ketamine research studies include Daniel Nishijima, MD.
Last updated: